P. Rigatti
- Urology top 0.5%
- Urinary Bladder and Prostate Research 25
- Urological Disorders and Treatments 13
- Psychiatry and Mental health top 2%
- Sexual function and dysfunction studies 18
-
- Hormonal and reproductive studies 15
-
- Prostate Cancer Diagnosis and Treatment 48
- Prostate Cancer Treatment and Research 34
- Renal cell carcinoma treatment 11
- Rheumatology top 5%
-
- Bladder and Urothelial Cancer Treatments 18
P. Rigatti
131 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 106
- Urology 560
- Psychiatry and Mental health 503
- Endocrinology, Diabetes and Metabolism 428
- Pulmonary and Respiratory Medicine 839
- Rheumatology 309
Countries citing papers authored by P. Rigatti
This map shows the geographic impact of P. Rigatti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Rigatti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Rigatti more than expected).
Fields of papers citing papers by P. Rigatti
This network shows the impact of papers produced by P. Rigatti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Rigatti. The network helps show where P. Rigatti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P. Rigatti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 0 | |
| 2 | 2010 | 35 | |
| 3 | Is immediate post-operative radiation of pT3NO prostate cancer a safe treatment? Results of EORTC-trial 22911. | 2003 | 2 |
| 4 | 2003 | 28 | |
| 5 | 2000 | 54 | |
| 6 | 2000 | 90 | |
| 7 | 1998 | 60 | |
| 8 | Local microwave-hyperthermia and intravesical chemotherapy with mitomycin C as neoadjuvant treatment for selected multifocal and unresectable superficial bladder tumors | 1995 | 2 |
| 9 | Clomipramine for premature ejaculation: A randomized, double-blind, placebo controlled study | 1995 | 8 |
| 10 | 1995 | 13 | |
| 11 | 1995 | 6 | |
| 12 | 1994 | 21 | |
| 13 | 1994 | 3 | |
| 14 | Endourethral prosthesis vs urethroplasty in the treatment of complex strictures of the bulbar urethra | 1993 | 1 |
| 15 | 1993 | 4 | |
| 16 | 1993 | 4 | |
| 17 | Neoadjuvant chemotherapy in deeply invasive bladder cancer: The Italian experience | 1990 | 1 |
| 18 | ESWL in the treatment of urolithiasis | 1989 | 1 |
| 19 | 1989 | 18 | |
| 20 | [Prevention of the recurrence of urinary lithiasis: mineral waters with high or low calcium content?]. | 1987 | 2 |
About P. Rigatti
P. Rigatti is a scholar working on Urology, Pulmonary and Respiratory Medicine, Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Rheumatology, having authored 139 papers that have together received 2.1k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (48 papers), Prostate Cancer Treatment and Research (34 papers), Urinary Bladder and Prostate Research (25 papers), Sexual function and dysfunction studies (18 papers), Bladder and Urothelial Cancer Treatments (18 papers), Hormonal and reproductive studies (15 papers), Urological Disorders and Treatments (13 papers) and Renal cell carcinoma treatment (11 papers). The work is most often cited by research in Urology (560 citations), Psychiatry and Mental health (503 citations), Endocrinology, Diabetes and Metabolism (428 citations), Pulmonary and Respiratory Medicine (839 citations) and Rheumatology (309 citations). P. Rigatti has collaborated with scholars based in Italy, Belgium and Germany. Frequent co-authors include Francesco Montorsi, Andrea Salonia, Giorgio Guazzoni, Vincenzo Scattoni, Renzo Colombo, A. Cestari, Alberto Briganti, Caterina Lania, Ferruccio Fazio and Matteo Castelli. Their work appears in journals such as European Urology, British Journal of Urology, European Urology Supplements, International Journal of Radiation Oncology*Biology*Physics and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.